AMICUS THERAPEUTICS, INC.
Pharmaceutical Preparations · 47 HULFISH STREET, PRINCETON, NJ 08542
官方登記資料
0位追蹤者
2002成立於
關於 AMICUS THERAPEUTICS, INC.
Amicus Therapeutics, Inc. is an American biopharmaceutical company based in Princeton, New Jersey. The company went public in 2007 under the Nasdaq trading symbol FOLD. This followed a 2006 planned offering and subsequent withdrawal, which would have established the trading symbol as AMTX Prior to their IPO, Amicus was funded by a variety of venture capital firms including Radius Ventures, Canaan Partners and New Enterprise Associates. As of April 2026, Amicus Therapeutics is a subsidiary of BioMarin Pharmaceutical.
Source: Wikipedia
產業Pharmaceutical Preparations
總部47 HULFISH STREET, PRINCETON, NJ 08542
成立時間2002
法律形式C Corporation
狀態營運中
專利649 項專利
METHODS OF TREATING FABRY DISEASE IN PATIENTS HAVING RENAL IMPAIRMENTKR20260090023A · 2026
Method for selection of high M6P recombinant proteinsTW202617983A · 2026
關鍵數據
法律資訊
| 法定名稱 | AMICUS THERAPEUTICS, INC. |
|---|---|
| 法律形式 | C Corporation |
| SEC CIK | 1178879在 SEC EDGAR 上查看 ↗ |
| EIN | 20-0422823 |
| 產業代碼(SIC) | 2834 |
| 登記地址 | 47 HULFISH STREET, PRINCETON, NJ 08542 |
| 狀態 | 營運中 |
來源: SEC EDGAR · 更新於 2026年10月15日